Evidence map›Paper›PMID 30962500›Full record

ArticleEuropean journal of human genetics : EJHG2019

Evaluation of telephone genetic counselling to facilitate germline BRCA1/2 testing in women with high-grade serous ovarian cancer.

Erin Tutty, Lara Petelin, Joanne McKinley, Mary-Anne Young, Bettina Meiser, Victoria M Rasmussen, Rowan Forbes Shepherd, Paul A James, Laura E Forrest

Open access · bronzeAbstract readEvaluation Study
In one paragraph

Article in European journal of human genetics : EJHG, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Virtual Care in Patients with Cancer: A Systematic Review.Current oncology (Toronto, Ont.) · 2021
    Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Patients' and professionals' perspective of non-in-person visits in hereditary cancer: predictors and impact of the COVID-19 pandemic.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  12. Evaluating the resource implications of different service delivery models for offering additional genomic findings.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  13. Article
  14. Cancer Genetic Counseling-Current Practice and Future Challenges.Cold Spring Harbor perspectives in medicine · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Erin TuttyParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Lara PetelinParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0003-3245-8895
Joanne McKinleyParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Mary-Anne YoungKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.
Bettina MeiserPrince of Wales Clinical School, University of New South Wales, Sydney, NSW, Australia.
Victoria M RasmussenParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Rowan Forbes ShepherdParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
Paul A JamesParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.ORCID 0000-0002-4361-4657
Laura E ForrestParkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. laura.forrest@petermac.org.ORCID 0000-0002-1126-4971
The University of Melbourne · AUPeter MacCallum Cancer Centre · AUGarvan Institute of Medical Research · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic healthcare issues and geographical challenges restrict women's access to BRCA1/2 testing to inform the use of tailored treatments for high-grade serous ovarian cancer. Consequently, BRCA1/2 testing in this population is low and improved testing pathways are urgently needed. This study aimed to determine the acceptability and feasibility of telephone genetic counselling (TGC) to facilitate treatment-focused BRCA1/2 testing in Australia for women with high-grade serous ovarian cancer. Women who received TGC were invited to complete a survey examining their experiences of the service. A cost analysis was conducted to compare the service to standard, in-person genetic counselling. One hundred and seven women responded (48% response rate); 8 had a BRCA1/2 variant affecting function. Geographical barriers prevented women from accessing genetic services in the past. All participants had a positive attitude towards testing, and regret following testing was minimal. While the impact of testing was greater for those with a positive test result, overall, genetic testing did not put the additional psychosocial burden on the participants. Participant's evaluations of the telephone interactions with the genetic counsellors were highly satisfactory. The service was also found to be cost-effective. This model of telephone genetic counselling was an acceptable and effective way to reduce barriers to BRCA1/2 testing for women with ovarian cancer.

Indexed as

AgedAged, 80 and overBRCA1 ProteinBRCA2 ProteinCost-Benefit AnalysisCystadenocarcinoma, SerousFemaleGenetic CounselingGenetic TestingGerm-Line MutationHumansMiddle AgedOvarian NeoplasmsPatient Acceptance of Health CareReproducibility of ResultsTelephoneBRCA1 ProteinBRCA2 Protein

Identifiers

PMID30962500
PMCPMC6777607
OpenAlexW2935969979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.